A detailed history of J.Safra Asset Management Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, J.Safra Asset Management Corp holds 31 shares of EXAS stock, worth $1,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 21 47.62%
Holding current value
$1,741
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025

BUY
$43.04 - $58.51 $430 - $585
10 Added 47.62%
31 $1,000
Q4 2024

Feb 06, 2025

BUY
$49.33 - $71.97 $98 - $143
2 Added 10.53%
21 $1,000
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $806 - $1,345
19 New
19 $1,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.94B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track J.Safra Asset Management Corp Portfolio

Follow J.Safra Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.Safra Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on J.Safra Asset Management Corp with notifications on news.